Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    8436430 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Study of gp75 Vaccine in Patients With Stage III and IV Melanoma
Condition: Malignant Melanoma
Intervention: Biological: gp75 DNA vaccine

Indicates status has not been verified in more than two years